Psoriasis Clinical Trials Recruiting in the US
46 studies for Psoriasis are recruiting at 309 US sites, according to ClinicalTrials.gov data processed .
Psoriasis is a long-term immune-related skin condition that causes raised, scaly patches on the skin.
Recruiting now
Top Psoriasis studies by number of US sites
Showing 30 studies, most US recruiting sites first.
- Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
NCT07116967
- Phase 3
- Ages 40 years and older
- Sex: All
- Recruiting sites
- 90 US recruiting sites
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
NCT03816345
- Phase 1
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 40 US recruiting sites
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
NCT06857942
- Phase 4
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 38 US recruiting sites
- A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
NCT06979453
- Phase 3
- Ages 12 to 17 years
- Sex: All
- Recruiting sites
- 27 US recruiting sites
- An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
NCT07449702
- Phase 2
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 26 US recruiting sites
- A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
NCT07250802
- Phase 3
- Ages 4 to 17 years
- Sex: All
- Recruiting sites
- 11 US recruiting sites
- Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
NCT07362017
- Phase 3
- Ages 18 to 65 years
- Sex: All
- Recruiting sites
- 10 US recruiting sites
- A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
NCT07219420
- Phase 3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 8 US recruiting sites
- A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
NCT07013201
- Phase 2
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 7 US recruiting sites
- A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
NCT06888193
- Phase 1
- Ages 18 years and older
- Sex: Female
- Recruiting sites
- 6 US recruiting sites
- Recruiting sites
- 3 US recruiting sites
- Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
NCT05642182
- Phase 1
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 3 US recruiting sites
- A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
NCT07489885
- Phase 2
- Ages 18 to 70 years
- Sex: All
- Recruiting sites
- 3 US recruiting sites
- A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
NCT07801495
- Phase 2
- Ages 18 to 100 years
- Sex: All
- Recruiting sites
- 3 US recruiting sites
- Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
NCT06982352
- Phase 1
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 2 US recruiting sites
- The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
NCT07487831
- Phase 4
- Ages 18 years and older
- Sex: All
- Accepts healthy volunteers
- Recruiting sites
- 2 US recruiting sites
- Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
NCT02103361
- Observational
- Ages Any age
- Sex: Female
- Recruiting sites
- 1 US recruiting site
- Recruiting sites
- 1 US recruiting site
- Regulation of Inflammatory Genes in Psoriasis
NCT03125655
- Observational
- Ages 19 to 99 years
- Sex: All
- Accepts healthy volunteers
- Recruiting sites
- 1 US recruiting site
- An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
NCT03392337
- Interventional
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 1 US recruiting site
- Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
NCT03827876
- Phase 4
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 1 US recruiting site
- Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis
NCT04036188
- Early Phase 1
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 1 US recruiting site
- Recruiting sites
- 1 US recruiting site
- Skin Microbial Ecology in Atopic Dermatitis
NCT04170244
- Observational
- Ages 13 years and older
- Sex: All
- Accepts healthy volunteers
- Recruiting sites
- 1 US recruiting site
- ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
NCT04347473
- Phase 4
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 1 US recruiting site
- Recruiting sites
- 1 US recruiting site
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
NCT04751396
- Observational
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 1 US recruiting site
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
NCT04806620
- Observational
- Ages 2 years and older
- Sex: All
- Accepts healthy volunteers
- Recruiting sites
- 1 US recruiting site
- Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
NCT04846959
- Observational
- Ages Any age
- Sex: Female
- Recruiting sites
- 1 US recruiting site
- Metabolic Profiling of Immune Responses in Immune-mediated Diseases
NCT04864886
- Observational
- Ages 18 to 75 years
- Sex: All
- Accepts healthy volunteers
- Recruiting sites
- 1 US recruiting site
By city
Psoriasis clinical trials by city
FAQ
Common questions
What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Psoriasis clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.